Skip to Main Content

Author Details

Huixian Hong
University of Alabama at Birmingham
2013
11
7
Jake Y. Chen (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36853618Brain and Systemic Inflammation in De Novo Parkinson's Disease.Mov Disord2023
36853618Brain and Systemic Inflammation in De Novo Parkinson's Disease.Mov Disord2023
34725967Host Genetics But Not Commensal Microbiota Determines the Initial Development of Systemic Autoimmune Disease in BXD2 Mice.Arthritis Rheumatol2022
34725967Host Genetics But Not Commensal Microbiota Determines the Initial Development of Systemic Autoimmune Disease in BXD2 Mice.Arthritis Rheumatol2022
34301844Protein Kinase CK2 Regulates B Cell Development and Differentiation.J Immunol2021
34301844Protein Kinase CK2 Regulates B Cell Development and Differentiation.J Immunol2021
32554431IL-23 Promotes a Coordinated B Cell Germinal Center Program for Class-Switch Recombination to IgG2b in BXD2 Mice.J Immunol2020
32554431IL-23 Promotes a Coordinated B Cell Germinal Center Program for Class-Switch Recombination to IgG2b in BXD2 Mice.J Immunol2020
28904124Cutting Edge: Endogenous IFN-β Regulates Survival and Development of Transitional B Cells.J Immunol2017
28904124Cutting Edge: Endogenous IFN-β Regulates Survival and Development of Transitional B Cells.J Immunol2017
28484220Electrophysiological Properties and Viability of Neonatal Rat Ventricular Myocyte Cultures with Inducible ChR2 Expression.Sci Rep2017
28484220Electrophysiological Properties and Viability of Neonatal Rat Ventricular Myocyte Cultures with Inducible ChR2 Expression.Sci Rep2017
26801735Inhibition of Transforming Growth Factor-β Activation Diminishes Tumor Progression and Osteolytic Bone Disease in Mouse Models of Multiple Myeloma.Am J Pathol2016
26801735Inhibition of Transforming Growth Factor-β Activation Diminishes Tumor Progression and Osteolytic Bone Disease in Mouse Models of Multiple Myeloma.Am J Pathol2016
26433944Impaired mitochondrial network excitability in failing guinea-pig cardiomyocytes.Cardiovasc Res2016
26433944Impaired mitochondrial network excitability in failing guinea-pig cardiomyocytes.Cardiovasc Res2016
25032991Molecular mechanism of thiazolidinedione-mediated inhibitory effects on osteoclastogenesis.PLoS One2014
25032991Molecular mechanism of thiazolidinedione-mediated inhibitory effects on osteoclastogenesis.PLoS One2014
23311882IL-11 produced by breast cancer cells augments osteoclastogenesis by sustaining the pool of osteoclast progenitor cells.BMC Cancer2013
24103757Interleukin-3 plays dual roles in osteoclastogenesis by promoting the development of osteoclast progenitors but inhibiting the osteoclastogenic process.Biochem Biophys Res Commun2013
23311882IL-11 produced by breast cancer cells augments osteoclastogenesis by sustaining the pool of osteoclast progenitor cells.BMC Cancer2013
24103757Interleukin-3 plays dual roles in osteoclastogenesis by promoting the development of osteoclast progenitors but inhibiting the osteoclastogenic process.Biochem Biophys Res Commun2013
  • 1 - 22 of 22

Recommended Authors

Karolinska Institute, Center for Molecular Medicine
Career Start Year 2012
Number of shared co-authors 0
Frederick National Laboratory for Cancer Research
Career Start Year 2011
Number of shared co-authors 0
Texas Children's Cancer Center
Career Start Year 2010
Number of shared co-authors 0
Peking University
Career Start Year 2009
Number of shared co-authors 0
University of Virginia School of Medicine, University of Virginia.
Career Start Year 2008
Number of shared co-authors 0
McGill University
Career Start Year 2008
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 2005
Number of shared co-authors 2
McGill University
Career Start Year 2003
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 2002
Number of shared co-authors 1
Pennsylvania State University College of Medicine
Career Start Year 2002
Number of shared co-authors 0
Yale University School of Medicine
Career Start Year 2001
Number of shared co-authors 0
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 2000
Number of shared co-authors 0
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 1998
Number of shared co-authors 0
Institute for Life and Medical Sciences, Kyoto University
Career Start Year 1991
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 1990
Number of shared co-authors 8
The University of Alabama at Birmingham
Career Start Year 1990
Number of shared co-authors 2
Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network
Career Start Year 1989
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 1989
Number of shared co-authors 0
University of Florida College of Medicine
Career Start Year 1989
Number of shared co-authors 0
Helen Wills Neuroscience Institute, University of California berkeley
Career Start Year 1988
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 1986
Number of shared co-authors 4
Oregon Health & Science University
Career Start Year 1984
Number of shared co-authors 0
National Institute of Arthritis, National Institutes of Health
Career Start Year 1984
Number of shared co-authors 1
University of Pittsburgh
Career Start Year 1982
Number of shared co-authors 0
Science Applications International Corporation/Frederick
Career Start Year 1981
Number of shared co-authors 0
University of Nebraska Medical Center
Career Start Year 1980
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 1975
Number of shared co-authors 0
The Jackson Laboratory Cancer Center
Career Start Year 1971
Number of shared co-authors 3
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1970
Number of shared co-authors 0
RIKEN Center for Integrative Medical Sciences (IMS)
Career Start Year 1966
Number of shared co-authors 0

Collaborators

University of Alabama at Birmingham and Birmingham VA Medical Center.
Co-authored papers 3
Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham
Co-authored papers 3
University of Michigan Medical School
Co-authored papers 2
University of Alabama at Birmingham Birmingham
Co-authored papers 2
University of Texas MD Anderson Cancer Center
Co-authored papers 2
University of Alabama at Birmingham
Co-authored papers 1
University of Alabama at Birmingham
Co-authored papers 1
University of Illinois College of Medicine Rockford
Co-authored papers 1
Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University
Co-authored papers 1
University of Colorado
Co-authored papers 1
Merck & Co., Inc.
Co-authored papers 1
University of Alabama at Birmingham (UAB)
Co-authored papers 1
Co-authored papers 1
University of Alabama at Birmingham
Co-authored papers 1
University of Alabama at Birmingham
Co-authored papers 1
Informatics Institute, the University of Alabama at Birmingham
Co-authored papers 1
Capital Medical University
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1